drugset / Trial / NCT00363935

Bariatric Dose-ranging Study With Dexmedetomidine

NCT00363935 ↗

RandomizedParallel-groupDouble-blind

Summary

After obtaining informed consent,80 morbidly obese ASA II-III patients undergoing laparoscopic bariatric surgery procedures would be randomly assigned to one of four study groups at UTSWMC at Dallas.Hemodynamic paarameters, recovery times, postoperative pain scores, the need for rescue analgesics and side effects will be recorded.The purpose of this study is to determine the optimal linfusion rate of dexmedetomidine for maintaining cardiovscular stability during general anesthesia.

Timeline

Start
2007-01-01
Primary completion
2007-01-01
Completion
2007-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —

Indications

No indication recorded.